OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells
Cindy Grandjenette, Anne Kennel, G Fauré, et al.
Haematologica (2007) Vol. 92, Iss. 9, pp. 1279-1281
Open Access | Times Cited: 40
Cindy Grandjenette, Anne Kennel, G Fauré, et al.
Haematologica (2007) Vol. 92, Iss. 9, pp. 1279-1281
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia
Justyna Rybka, Aleksandra Butrym, Tomasz Wróbel, et al.
Archivum Immunologiae et Therapiae Experimentalis (2016) Vol. 64, Iss. S1, pp. 147-150
Open Access | Times Cited: 12
Justyna Rybka, Aleksandra Butrym, Tomasz Wróbel, et al.
Archivum Immunologiae et Therapiae Experimentalis (2016) Vol. 64, Iss. S1, pp. 147-150
Open Access | Times Cited: 12
GIFT4 fusokine converts leukemic B cells into immune helper cells
Jiusheng Deng, Andrea Pennati, Jonathon B. Cohen, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Jiusheng Deng, Andrea Pennati, Jonathon B. Cohen, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation
Shimrit Ringelstein‐Harlev, Irit Avivi, Mona Fanadka, et al.
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 5, pp. 739-748
Closed Access | Times Cited: 10
Shimrit Ringelstein‐Harlev, Irit Avivi, Mona Fanadka, et al.
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 5, pp. 739-748
Closed Access | Times Cited: 10
Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
Katarzyna Skórka, Paulina Własiuk, Agnieszka Karczmarczyk, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 867-867
Open Access | Times Cited: 7
Katarzyna Skórka, Paulina Własiuk, Agnieszka Karczmarczyk, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 867-867
Open Access | Times Cited: 7
Myeloid cell leukaemia 1 has a vital role in retinoic acid‐mediated protection of T oll‐like receptor 9‐stimulated B cells from spontaneous and DNA damage‐induced apoptosis
Kristine Lillebø Holm, Randi Larsen Indrevær, June H. Myklebust, et al.
Immunology (2016) Vol. 149, Iss. 1, pp. 62-73
Open Access | Times Cited: 6
Kristine Lillebø Holm, Randi Larsen Indrevær, June H. Myklebust, et al.
Immunology (2016) Vol. 149, Iss. 1, pp. 62-73
Open Access | Times Cited: 6
TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia
Agata Szymańska, Agnieszka Bojarska‐Junak, Arkadiusz Drobiecki, et al.
Archivum Immunologiae et Therapiae Experimentalis (2018) Vol. 67, Iss. 1, pp. 55-65
Open Access | Times Cited: 5
Agata Szymańska, Agnieszka Bojarska‐Junak, Arkadiusz Drobiecki, et al.
Archivum Immunologiae et Therapiae Experimentalis (2018) Vol. 67, Iss. 1, pp. 55-65
Open Access | Times Cited: 5
Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod
Min Chen, Manoel de Carvalho, Pierre Feugier, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2011) Vol. 53, Iss. 4, pp. 739-742
Closed Access | Times Cited: 4
Min Chen, Manoel de Carvalho, Pierre Feugier, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2011) Vol. 53, Iss. 4, pp. 739-742
Closed Access | Times Cited: 4
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma
Aurélie Verney, Alexandra Traverse‐Glehen, Evelyne Callet‐Bauchu, et al.
Oncotarget (2018) Vol. 9, Iss. 34, pp. 23589-23598
Open Access | Times Cited: 4
Aurélie Verney, Alexandra Traverse‐Glehen, Evelyne Callet‐Bauchu, et al.
Oncotarget (2018) Vol. 9, Iss. 34, pp. 23589-23598
Open Access | Times Cited: 4
Nitric Oxide and Life or Death of Human Leukemia Cells
J. Brice Weinberg
Springer eBooks (2010), pp. 147-167
Closed Access | Times Cited: 3
J. Brice Weinberg
Springer eBooks (2010), pp. 147-167
Closed Access | Times Cited: 3
Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia—Any Link with Known Prognostic Factors?
Ewelina Grywalska, Michał Mielnik, Martyna Podgajna, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 672-672
Open Access | Times Cited: 2
Ewelina Grywalska, Michał Mielnik, Martyna Podgajna, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 672-672
Open Access | Times Cited: 2
Stimulation of Toll-Like Receptor-7 Enhances BAFF and APRIL Pathways of Survival in Chronic Lymphocytic Leukemia Cells
Amar Hammadi, Christian Billard, Brigitte Bauvois, et al.
The Open Leukemia Journal (2010) Vol. 3, Iss. 1, pp. 24-33
Open Access | Times Cited: 1
Amar Hammadi, Christian Billard, Brigitte Bauvois, et al.
The Open Leukemia Journal (2010) Vol. 3, Iss. 1, pp. 24-33
Open Access | Times Cited: 1
Morphology and Immunophenotype of Chronic Lymphocytic Leukemia
Mir Alikhan, Girish Venkataraman
Springer eBooks (2017), pp. 79-98
Closed Access | Times Cited: 1
Mir Alikhan, Girish Venkataraman
Springer eBooks (2017), pp. 79-98
Closed Access | Times Cited: 1
Discovering Causal Patterns with Structural Equation Modeling: Application to Toll‐Like Receptor Signaling Pathway in Chronic Lymphocytic Leukemia
Athina Tsanousa, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
(2015), pp. 555-584
Closed Access
Athina Tsanousa, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
(2015), pp. 555-584
Closed Access
